Drug Trial Radar · NCT07415954
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
270
Planned (sponsor's estimate)
Start
Apr 17, 2026
Primary completion
Sep 3, 2027
Study completion Oct 1, 2027
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Feb 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being done to look at the effect and safety of different doses of NNC0662-0419 in people living with type 2 diabetes when compared to placebo or semaglutide. The purpose of this clinical study is to find out if NNC0662-0419 is effective and safe for treating people living with type 2 diabetes. Participants will get either NNC0662-0419, semaglutide or placebo. Which treatment participants get is decided by chance. NNC0662-0419 is a new medicine which cannot be prescribed by doctors but has previously been tested in humans. Semaglutide is an approved medication to treat type 2 diabetes.
Conditions
- Diabetes Mellitus, Type 2
Interventions
NNC0662-0419Drug
NNC0662-0419 will be administered subcutaneously.
SemaglutideDrug
Semaglutide will be administered subcutaneously.
PlaceboDrug
Placebo will be administered subcutaneously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in glycated haemoglobin (HbA1c) (week 16)Time frame: From baseline (week 0) to week 16
- Change in HbA1c (week 28)Time frame: From baseline (week 0) to week 28
- Change in HbA1c (week 40)Time frame: From baseline (week 0) to week 40
Locations
63 sites in 10 countries. Site status is shown where the registry gives one.
First Valley Medical Group
Lancaster, California · Recruiting
Torrance Clinical Research Institute, Inc.
Lomita, California · Recruiting
Ark Clinical Research
Long Beach, California · Recruiting
Pacific Clinical Studies
Los Alamitos, California · Recruiting
Wetlin Research Associates, Inc.
San Diego, California · Recruiting
Diablo Clinical Research, Inc.
Walnut Creek, California · Recruiting
Encore Medical Research LLC
Hollywood, Florida · Recruiting
Bioclinical Research Alliance
Miami, Florida · Recruiting
South Broward Research LLC
Miramar, Florida · Recruiting
West Orange Endocrinology
Ocoee, Florida · Not yet recruiting
Encore Medical Research of Weston
Weston, Florida · Recruiting
Elite Clinical Trials
Blackfoot, Idaho · Recruiting
Cedar-Crosse Research Center
Chicago, Illinois · Recruiting
Brigham & Women's Hospital
Boston, Massachusetts · Not yet recruiting
Headlands Research
Springfield, Missouri · Recruiting
PharmQuest
Greensboro, North Carolina · Recruiting
Piedmont Healthcare Statesville
Statesville, North Carolina · Recruiting
Providence Center for Clinical Research
Dayton, Ohio · Recruiting
CNS Healthcare
Memphis, Tennessee · Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas · Recruiting
JCCT- Juno NW Houston
Houston, Texas · Recruiting
Consano Clinical Research, LLC
Shavano Park, Texas · Recruiting
Frontier Clinical Research - Kingwood
Kingwood, West Virginia · Not yet recruiting
Opca bolnica Karlovac
Karlovac, Croatia · Recruiting
Poliklinika SLAVONIJA OSIJEK
Osijek, Croatia · Recruiting
Opca bolnica Varazdin_Endocrinology
Varaždin, Croatia · Recruiting
Poliklinika Solmed
Zagreb, Croatia · Recruiting
Debreceni Egyetem
Debrecen, Hungary · Not yet recruiting
Szegedi Tudomanyegyetem St Györgyi Albert Klinikai Központ
Szeged, Csongrád-Csanád, Hungary · Not yet recruiting
Debreceni Egyetem
Debrecen, Hajdú-Bihar, Hungary · Not yet recruiting
Akaicho Clinic_Internal medicine
Chiba-shi, Chiba, Japan · Active not recruiting
Naka Kinen Clinic_Internal medicine
Ibaraki, Japan · Active not recruiting
Soka Sugiura Internal Medicine Clinic
Soka-shi, Saitama, Japan · Active not recruiting
Tokyo-Eki Center-building Clinic_Internal Medicine
Tokyo, Japan · Active not recruiting
ToCROM Clinic_Internal Medicine
Tokyo, Japan · Active not recruiting
Terpa Sp. z o.o. Sp. k.
Lublin, Poland · Not yet recruiting
Formed 2 Sp. z o.o.
Oświęcim, Poland · Recruiting
PANSTWOWY INSTYTUT MEDYCZNY MSWiA
Warsaw, Poland · Recruiting
Samodzielny Publiczny Szpital Kliniczny Nr 1 im. Prof. Szyszko
Zabrze, Poland · Recruiting
"Zdrowie Osteo-Medic" s.c. Lidia i Artur Racewicz, Agnieszka i Jerzy Supronik
Bialystok, Podlaskie Voivodeship, Poland · Recruiting
Showing 40 of 63 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.